Horizon Therapeutics Public Ltd Co

Tower Research Capital LLC (TRC)

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

459

Value ($000)

53

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	53	0.0%	459	9/30/2023
2023 Q2	8/14/2023	312	0.0%	3,029	6/30/2023
2023 Q1	5/9/2023	1,030	0.0%	9,439	3/31/2023
2022 Q4	2/10/2023	718	0.0%	6,313	12/31/2022
2022 Q3	11/10/2022	708	0.0%	11,437	9/30/2022
2022 Q2	8/15/2022	1,218	0.0%	15,277	6/30/2022
2022 Q1	5/12/2022	661	0.0%	6,287	3/31/2022
2021 Q4	2/14/2022	1,078	0.0%	9,996	12/31/2021
2021 Q3	11/15/2021	175	0.0%	1,601	9/30/2021
2021 Q2	8/16/2021	1,349	0.0%	14,407	6/30/2021
2021 Q1	5/17/2021	327	0.0%	3,554	3/31/2021
2020 Q4	2/16/2021	463	0.0%	6,332	12/31/2020
2020 Q3	11/16/2020	853	0.0%	10,976	9/30/2020
2020 Q2	8/13/2020	55	0.0%	983	6/30/2020
2020 Q1	5/15/2020	114	0.0%	3,874	3/31/2020
2019 Q4	2/7/2020	19	0.0%	522	12/31/2019